Theriva Biologics Inc (TOVX): Hi Citrati! I've been in New Orleans for...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Theriva Biologics Inc (TOVX)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	74
Posts	1863
Boards Moderated	0
Alias Born	04/30/2011

Re: Citrati post# 7260

Thursday, 01/26/2017 5:16:35 PM

Thursday, January 26, 2017 5:16:35 PM

Hi Citrati! I've been in New Orleans for the past couple of weeks and am just catching up on posts. My thoughts are that SYN will trial both drugs successfully thru ph3 and FDA approval. Very unusual for a small biotech to pull that off but I think they will. Finances continue to be a concern, to all of us I'm sure. They need a 1 or 2 partnerships desperately.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent TOVX News

Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 01:10:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:10:38 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:07:49 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:01:42 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:00:21 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:00:19 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:15:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 11:10:42 AM
Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 10:05:12 AM
Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 10:06:35 AM
Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 08/16/2023 09:24:26 PM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/15/2023 01:53:41 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/14/2023 09:11:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 08:30:38 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 01:03:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 12:10:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2023 01:22:02 PM
Another Biotech Stealing The Premarket Spotlight • AllPennyStocks.com • 06/28/2023 02:15:00 PM

More TOVX News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow